Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-05-20

Clinical Trial Update: Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine [Phase 4]

View source ↗

Summary

Update on a Phase 4 trial evaluating the immunogenicity of one or two doses of the bivalent oral poliovirus vaccine in Chilean infants primed with inactivated p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IPV (Inactivated poliovirus vaccine)
  • bOPV (bivalent oral polio vaccine)

Snippet

Sponsor: University of Chile | Conditions: Polio | Phase 4 | Status: UNKNOWN